Unknown

Dataset Information

0

Plasma creatine and incident type 2 diabetes in a general population-based cohort: The PREVEND study.


ABSTRACT:

Background

Type 2 diabetes is associated with both impaired insulin action at target tissues and impaired insulin secretion in pancreatic beta cells. Mitochondrial dysfunction may play a role in both insulin resistance and impaired insulin secretion. Plasma creatine has been proposed as a potential marker for mitochondrial dysfunction. We aimed to investigate the association between plasma creatine and incident type 2 diabetes.

Methods

We measured fasting plasma creatine concentrations by nuclear magnetic resonance spectroscopy in participants of the general population-based PREVEND study. The study outcome was incident type 2 diabetes, defined as a fasting plasma glucose ≥7.0 mmol/L (126 mg/dl); a random sample plasma glucose ≥11.1 mmol/L (200 mg/dl); self-report of a physician diagnosis or the use of glucose-lowering medications based on a central pharmacy registration. Associations of plasma creatine with type 2 diabetes were quantified using Cox proportional hazards models and were adjusted for potential confounders.

Results

We included 4735 participants aged 52 ± 11 years, of whom 49% were male. Mean plasma creatine concentrations were 36.7 ± 17.6 µmol/L, with lower concentrations in males than in females (30.4 ± 15.1 µmol/L vs. 42.7 ± 17.7 µmol/L; p for difference <.001). During 7.3 [6.2-7.7] years of follow-up, 235 (5.4%) participants developed type 2 diabetes. Higher plasma creatine concentrations were associated with an increased risk of incident type 2 diabetes (HR per SD change: 1.27 [95% CI: 1.11-1.44]; p < .001), independent of potential confounders. This association was strongly modified by sex (p interaction <.001). Higher plasma creatine was associated with an increased risk of incident type 2 diabetes in males (HR: 1.40 [1.17-1.67]; p < .001), but not in females (HR: 1.10 [0.90-1.34]; p = .37).

Conclusion

Fasting plasma creatine concentrations are lower in males than in females. Higher plasma creatine is associated with an increased risk of type 2 diabetes in males.

SUBMITTER: Post A 

PROVIDER: S-EPMC8048485 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8707837 | biostudies-literature
| S-EPMC6306832 | biostudies-literature
| S-EPMC7563197 | biostudies-literature
| S-EPMC9323856 | biostudies-literature
| S-EPMC9206357 | biostudies-literature
| S-EPMC3664562 | biostudies-literature
| S-EPMC5965821 | biostudies-literature
| S-EPMC8669796 | biostudies-literature
| S-EPMC5291433 | biostudies-literature
| S-EPMC6323092 | biostudies-literature